Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    16675550 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Effects of Treatment With Aprepitant (Emend®) in HIV Infected Individuals
Condition: HIV Infections
Interventions: Drug: Placebo;   Drug: Aprepitant
2 Completed Effects of Treatment With Aprepitant (Emend®) in HIV Infected Individuals. 375 mg Dose
Condition: HIV Infection
Interventions: Drug: Aprepitant;   Drug: Aprepitant placebo

Indicates status has not been verified in more than two years